TCL Archive Velcade Addition Can Improve Graft-Versus-Host Outcomes By Cancer History Project December 27, 2013
TCL Archive NCI CTEP Approved Trials For the Month of December By Cancer History Project December 27, 2013
TCL Archive FDA Expands Nexavar Indication To Include Thyroid Cancer By Cancer History Project December 27, 2013
TCL Archive Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock By Cancer History Project December 17, 2013
TCL Archive An Earmark In The Making? NCI Urged to Boost Gastric Cancer Funding By Cancer History Project December 17, 2013
TCL Archive In Brief: LENORA JOHNSON Was Named Director Of Health Education, Communications, And Science Policy at the National Heart Lung and Blood Institute By Cancer History Project December 17, 2013
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. By Cancer History Project December 17, 2013
TCL Archive What Is and Isn’t a Crime in Texas: CPRIT Official Indicted For Skipping Peer Review By Cancer History Project December 13, 2013
Article Elaine Nord, photographer and neuroendocrine cancer survivor, speaks at the 2024 NETRF Symposium By NETRF
Article Ramesh Shivdasani: Viewing Intestinal NETs Through the Lens of Normal Human Enteroendocrine Cell Differentiation By NETRF
